Colchicine to lower heart artery swelling in HIV
Treatments studied
Part of Heart & circulation, Immune system & allergy, Infections clinical trials.
This trial tests if colchicine, a medicine for inflammation, can reduce swelling in the heart arteries of people with HIV. It may help lower the risk of heart problems in those already on a statin or similar medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 50 years old and have HIV
- Your HIV should be well-controlled with antiretroviral therapy for at least 6 months, with a low viral load for the past year
- You need a higher-than-average heart disease risk (SCORE-2 over 5%)
- You must be on a stable dose of a statin or similar cholesterol medication for the past year
- You cannot have had a heart attack, stroke, or certain other medical conditions like severe heart failure, kidney problems, or active cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the drug colchicine can reduce inflammation in people with coronary heart disease who have had a stent placed. It aims to see if colchicine helps improve heart health by lowering inflammation.
This study tests whether a daily low dose of colchicine, a medicine used for gout and inflammation, can reduce inflammation and improve blood vessel and bone health in people with chronic kidney disease. It might help prevent complications like heart disease and weak bones.
This trial tests if the anti-inflammatory drug colchicine can help people hospitalized with acute heart failure and a weak heart pump. It may benefit those with elevated inflammation markers.
This trial tests whether a daily low-dose of colchicine, a common anti-inflammatory medicine, can help prevent heart attacks and strokes in people with type 2 diabetes who do not yet have heart disease. If it works, it could be a simple addition to your current diabetes care.
This trial tests whether a low-dose colchicine (LoDoCo) can help people with heart failure and inflammation feel better and exercise more. It is for adults 50 and older with HFpEF who have signs of inflammation in their blood.
This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.
Hear when a new Cardiovascular Diseases (CVD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.